German-French Bilateral Meeting
4-5th Nov 2019 | Mannheim, Germany
Challenges and Solutions in the Fields of ‘Artificial Intelligence in Health’ and ‘Antimicrobial Resistance’.

EIT Health Germany Annual Symposium 2019
(in collaboration with EIT Health France)

Two Countries, Two Topics, Two Days, One Target:

Challenges and Solutions in the Fields of ‘Artificial Intelligence in Health’ and ‘Antimicrobial Resistance’ –

A German-French Bilateral Meeting

Monday, 4 November 2019 11:30–Tuesday, 5 November 2019 16:00
Venue: Roche Diagnostics GmbH (Open Campus Mannheim)
Sandhofer Straße 116
68305 Mannheim

For this year’s EIT Health Germany Annual Symposium we will join forces with EIT Health France to focus on cross-border cooperation in two very important fields: “Artificial Intelligence in Health” and “Antimicrobial Resistance”.

A plethora of challenging questions need to be answered to achieve progress in both fields now and for the future, and over the course of this bilateral meeting we aim to stimulate open discussion on both topics as well as develop and exchange ideas for exciting future projects and programmes.

All EIT Health Germany and EIT Health France Core, Associate and Network Partners as well as key players and stakeholders from the German, Swiss and French healthcare innovation ecosystems are invited to join us. (Seats are limited and preference will be given to official partners of EIT Health Germany and EIT Health France)

For this unique Event, novel ideas and projects in the fields of “AI” and “AMR” will be showcased [Abstract Deadline expired!].

Register for the event here [Click].

Agenda Day 1
(Monday, 4 November 2019)

10:30 – 11:30 EIT Health Partner Meeting (German Partners only)
11:30 – 13:00 Registration, Lunch & Poster Exhibition
13:00-13:30 Welcome
Dr. Katharina Ladewig,
Managing Director, EIT Health Germany 
Since October 2015, Dr. Katharina Ladewig is part of the Management Board at EIT Health. While formerly working as Managing Director in GB/Ireland, she was appointed MD of EIT Health Germany in January 2018. Katharina was educated in both Germany and Australia and holds degrees in natural sciences (MSc – Chemistry 2005), Engineering (PhD – Biomedical Engineering 2009) and Business Management (MBA 2015). Before starting her career at EIT Health, she worked in Universities in both countries and focused mainly on translation activities and the expansion of innovation partnerships.
Jean-Marc Bourez,
Managing Director, EIT Health France
Jean Marc Bourez has experienced different positions in pharma industry since 1992, Commercial Operations, Medical Affairs, Strategic Marketing, Business Excellence, Business Development Strategy and Open Innovation.Former head of eHealth & Open Innovation process at Sanofi, he has been appointed as CEO of EIT Health France in 2016. In this position, Jean-Marc is leading a collaborative project with the European Investment Fund to develop a pan-European Platform of co-investment in Life sciences.
Ministry of Science, Research and the Arts of the state of Baden-Württemberg 
13:30 – 15:00 Keynote:
Can Artificial Intelligence mitigate the global challenge of antimicrobial resistance?
Prof. Lothar H. Wieler, President, Robert Koch Institute (RKI)
The Robert Koch Institute has an important and specific role in surveillance and research on AMR on a national and global level. I will describe our duties and innovations in AMR data analyses by machine learning algorithms.
15:00-15:30 Afternoon Tea & Poster Exhibition
(optional: Tour Virtual Reality Lab at Roche)
Experience the Roche Integrated Core Lab throughout the latest Real-Time and Virtual Reality Technologies. Simply don a head-mounted display like the Oculus Rift or navigate through a lab on our 7 meter projection Powerwall.
15:30 – 17:00 Pitching Sessions
Sepsis, a challenge for Artificial Intelligence
Julien Textoris, Global Medical Affairs Director,
Alexandre Pachot, Director Open Innovation & Partnerships Department,
bioMérieux 
We will review Sepsis unmet medical needs, recent advances in predicting sepsis, identifying the causing pathogen, analyzing the host immune response and how it may provide opportunities for new therapeutics opportunities, including modern fight against AMR.

AI-Powered Molecular Drug Response Detection to Inform Antibiotic Precision Therapy
Dr. Andreas Posch, CEO, Ares Genetics GmbH
This talk discusses the development of a molecular drug response test based on ARESdb, a unique knowledgebase combining genetic information for 30,000+ pathogens and susceptibility data for 100+ antibiotics.
Abtrace: Getting antibiotics right
Helder Soares, Founder and CSO, Abstrace ltd
AI based solution to tackle variation in antibiotic prescribing across healthcare, with benefits to patients, healthcare costs and societal impact of AMR.
bioMérieux EPISEQ® as a routine tool for genomic tracing of outbreaks of hospital-acquired infections
Dr. Alex van Belkum, Microbiologist, bioMérieux
We developed a tool that will help clinicians with the interpretation of WGS data. EPISEQ® CS is a recently launched SaaS that generates epidemiological interpretation combined with antibiotic resistance- and virulence-related information at the push of a button with results within the hour.
PathoSept: Fast resistance profiling for sepsis treatment
Lorenz Sparrenberg, Research Assistant, Fraunhofer FIT 
Fraunhofer FIT introduces a fast antibiotic susceptibility testing system. Using standardized microtiter plates (96/384 well), the system analyzes bacterial cultures automatically and in parallel.
Spindiag: How to detect multiresistant bacteria in 30 minutes at the point-of-care
Dr. Daniel Mark, CEO, Spindiag GmbH
Spindiag develops a simple point-of-care diagnostic system for the fast, safe and efficient screening of incoming patients for multidrug-resistant bacteria as one of our ten threats to global Health.
17:15 – 18:30 Get-together and Apéritif
18:30 – 21:00 Dinner

Agenda Day 2
(Tuesday, 5 November 2019)

09:30 – 10:00 Light Breakfast & Coffee
10:00 – 12:00 Pitching Sessions
Rethinking critical care – New approaches to big data in the intensive care domain
Dr. Arne Peine, Project Lead, Dr. med. Lukas Martin, Group Lead, University Hospital RWTH Aachen  
Complexity of accurate, evidence-based medicine increases steadily. New approaches apply state-of-the-art Machine Learning algorithms, uncover relevant data patterns in patient data, detect life-threatening diseases and improve overview.
Artificial intelligence to support doctors in their therapy decision
Jacques Ehret, CSO, RAMPmedical 
RAMPmedical reduces costs and improves the quality of care with their therapy decision support software that combines AI, state of the art knowledge and patient data.
Deep Speech Analysis for Clinical Trials (DeepSpA): Novel Digitalized Markers for Screening & Monitoring of patients 
Johannes Tröger, Researcher, German Research Center for Artificial Intelligence (DFKI)
Presentation of the DeepSpA project: Deep Speech Analysis for Clinical Trials. Demo of two of its remote uses cases: (1) telephone-based clinician-supported neurocognitive testing with the ∆elta platform (www.ki-elements.de) and (2) fully automated telephone-based testing for better scalability. Results from the ongoing feasibility study + preliminary results from machine learning experiments to automatically screen for patients at risk will be presented.
RealWorld4Clinic – a new EIT Health Innovation Project
Prof. Freimut Schliess, Director Science & Innovation, Profil GmbH
RealWorld4Clinic launches the MySentinel implantable device collecting cardio-respiratory health data for an AI-based improvement of outcomes for persons with heart failure and drug developers.
A novel fragment based Carbapenemase inhibitor
Dr. Hannelore Meyer, Group Leader, Technical University Munich
Carbapenemases mediate resistance to the most frequently used class of antibiotics (ß-lactams). We describe two novel and potent fragment-based classes of broad spectrum carbapenemase Inhibitors.
Bacteriophages – old anti-infectives with new perspectives
Dr. Holger Ziehr, Division Director, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM)
Fraunhofer ITEM is performing bacteriophage bioprocess development for years and is actually executing for clients 4 different phage projects focusing on manufacturing of clinical grade phage and phage-lysins for the eradication of MRSA, VRE, multi-resistant Ps. aeruginosa and A. baumannii.
Fighting Periodontitis – Molecular Trojan Horses for Holistic Therapies
Pierre Tangermann, CEO, PerioTrap Pharmaceuticals GmbH
PerioTrap develops a new selective therapy for periodontitis that only targets the key pathogens of the disease. Therefore, the protective physiological biofilm remains untouched.
aBACTER: Next generation antibiotics for difficult-to-treat bacterial infections
Dr. Christian Fetzer
Scientist, Technical University Munich – aBACTER 
aBACTER is an innovative pre-seed project focused on the development of novel antibiotics exhibiting excellent potency against multi-resistant pathogens while showing no detectable resistance-development.
12:00 – 13:00 Lunch & Poster Exhibition
13:00 – 15:00 Roundtables EIT Health partners and supported start-ups will host roundtable discussions on “AI” and “AMR” to explore new Project ideas and collaboration opportunities. The main goal is to create project proposals for the EIT Health Business Plan 2021 and to foster activities in the EIT Health portfolio around the topics of artificial intelligence and antimicrobial resistance. There will be two rounds of roundtables which will be facilitated by the Team members of the German and French CLC.
15:00 – 15:45 Keynote:
AI in Medicine between Vision and Disruption
Prof. Andreas Dengel, Executive Scientific Director, German Research Center for Artificial Intelligence (DFKI)
Based on the availability of data, Artificial Intelligence (AI) can be used to transfer more and more cognitive tasks to computers that learn from human behaviour. By doing so, they help to improve our understanding, increase our problem-solving capacity or simply help us remember. In this talk, it will be adressed how Artificial Intelligence may be employed for supporting medical processes, diagnoses as well as image understanding.
15:45 Coffee and Closure

Travel Description and Parking Facilities at Roche

Please use the signposted parking lots of the OCM (Building No. 117, accesss via Sandhofer Straße) or the visitor parking B2 (access via Zellstoff Straße). In order to enter the parking lots, please press the call button and indicate the name of the event („EIT Health – Annual Symposium“). »Travel description

Accomodations in Mannheim

Please note that tha booking Deadline for our hotel contingents has expired. Nevertheless, we still recommend the following hotel with an excellent connection to Mannheim Main Station:

Hilton Garden Inn Mannheim

Past Annual Symposia

EIT Health Germany Annual Symposium 2018 & Ideation Workshop

“Supporting Care in an Interconnected World”

Under the topic of “Supporting Care in an Interconntected World”, EIT Health Germany invited
all EIT Health partners, health-related stakeholders and participants of the ecosystem to join
its Annual Symposium (including Partner Assembly of EIT Health Germany on 23 October) last year. For two days we focused on discussing, exchanging and most importantly drafting concrete project ideas in two of the EIT Health Focus Areas “Bringing Care Home” and “Real World Data”.

This event was a great opportunity to bring novel ideas, knowledge and technologies to the
table aiming to support care in an interconntected world, as well as to share results of already
ongoing projects on which new EIT Health activities could be developed.

EU Keynote Speaker

  • Birgit Morlion, DG CONNECT, European Commission
  • Zayna Khayat, SE Health & Singularity University

Other Programme Highlights

  • Presentations from Regional & EU-Level Speakers on the Topic of “Creating Value through Collaborations – Connecting to the Ecosystem”
    • Bernd Finger, Ministry of Science Research and the Arts Baden-Württemberg
    • Roberto Zuffada, European Innovation Partnership on Active and Healthy Ageing (EIP-AHA)
    • Nicola Filizola, Communication & Public Affairs, Ambient-Assisted Living (AAL) Initiative
  • Gala Dinner with Final Entrepreneurship Showcases aboard the ship “Königin Silvia”
  • Guided roundtable discussions leading to project ideas for future EIT Health calls for proposals
  • Scheduled individual meetings with three partners à 20 minutes plus free networking spaces and opportunities

Picture Gallery 2017

A selection of pictures of the German EIT Health Annual Symposium 2017.

Impressions from our Annual Symposium 2016

Subscribe to our mailing list

Do you want to find out more about EIT Health at national and international level? Submit your email-address to subscribe to our bi-monthly CLC Newsletter.

Subscribe now
Back to top
Image of

Close